Filed Pursuant to Rule 424(b)(2)
File No. 333-195697
| ||||||||
Title of Each Class of Securities Offered |
Amount to be Registered |
Maximum Offering Price Per Security |
Maximum Aggregate Offering Price |
Amount of
| ||||
Medium Term Notes, Series N, Floating Rate Notes
|
$450,000,000 | 100.00% | $450,000,000 | $57,960 | ||||
| ||||||||
|
(1) | The total filing fee of $57,960 is calculated in accordance with Rule 457(r) of the Securities Act of 1933 (the Securities Act) and will be paid by wire transfer within the time required by Rule 456(b) of the Securities Act. |
Pricing Supplement No. 3 dated September 2, 2014
(to Prospectus Supplement dated May 30, 2014
and Prospectus dated May 5, 2014)
WELLS FARGO & COMPANY
Medium-Term Notes, Series N
Floating Rate Notes
Aggregate Principal Amount Offered: | $450,000,000 | |
Trade Date: | September 2, 2014 | |
Original Issue Date (T+5): | September 9, 2014 | |
Stated Maturity Date: | September 8, 2017 | |
Price to Public (Issue Price): | 100.00%, plus accrued interest, if any, from September 9, 2014 | |
Agent Discount (Gross Spread): | 0.25% | |
All-In Price (Net of Agent Discount): | 99.75%, plus accrued interest, if any, from September 9, 2014 | |
Net Proceeds: | $448,875,000 | |
Benchmark: | Three-month LIBOR | |
Base Rate: | LIBOR | |
Spread: | +26 basis points | |
Designated LIBOR Page: | Page LIBOR01 as displayed on Reuters or any successor service (or such other page as may replace Page LIBOR01 on that service or successor service) | |
Index Maturity: | Three months | |
Interest Reset Periods: | Quarterly | |
Interest Reset Dates: | Each March 8, June 8, September 8 and December 8, commencing December 8, 2014 and ending June 8, 2017 | |
Interest Payment Dates: | Each March 8, June 8, September 8 and December 8, commencing December 8, 2014 and at maturity | |
Initial Interest Rate: | Three-month LIBOR plus 0.26%, determined two London banking days prior to September 9, 2014 | |
Redemption: | The notes are not redeemable at the option of Wells Fargo & Company |
Listing: | None |
Principal Amount | ||||||
Agent (Sole Bookrunner): | Wells Fargo Securities, LLC |
$ | 360,000,000 | |||
Agent (Co-Managers): | ANZ Securities, Inc. |
13,500,000 | ||||
BB Securities Limited |
13,500,000 | |||||
BB&T Capital Markets, |
||||||
a division of BB&T Securities, LLC |
13,500,000 | |||||
CIBC World Markets Corp. |
13,500,000 | |||||
Desjardins Securities Inc. |
13,500,000 | |||||
TD Securities (USA) LLC |
13,500,000 | |||||
Agent (Junior Co-Managers): | Apto Partners, LLC |
2,250,000 | ||||
Blaylock Beal Van, LLC |
2,250,000 | |||||
Loop Capital Markets LLC |
2,250,000 | |||||
Samuel A. Ramirez & Company, Inc. |
2,250,000 | |||||
Total: |
$ | 450,000,000 |
Plan of Distribution: | On September 2, 2014, Wells Fargo & Company agreed to sell to the Agents, and the Agents agreed to purchase, the notes at a purchase price of 99.75%, plus accrued interest, if any, from September 9, 2014. The purchase price equals the issue price of 100.00% less a discount of 0.25% of the principal amount of the notes. | |
BB Securities Limited is not a broker-dealer registered with the Securities and Exchange Commission, and therefore may not make sales of any notes in the United States or to U.S. persons except in compliance with applicable U.S. laws and regulations. To the extent that BB Securities Limited intends to effect sales of the notes in the United States, it will do so only through Banco do Brasil Securities LLC or one or more U.S. registered broker-dealers, or otherwise as permitted by applicable U.S. law. BB Securities Asia Pte. Ltd. may be involved in the sales of the notes in Asia. | ||
Desjardins Securities Inc. is not a U.S. registered broker-dealer, and, therefore, will not effect any offers or sales of any notes in the United States or will do so only through one or more registered broker-dealers as permitted by the regulations of the Financial Industry Regulatory Authority, Inc. | ||
Certain U.S. Federal Income Tax Consequences: |
Tax considerations are discussed under Certain U.S. Federal Income Tax Considerations in the accompanying prospectus. | |
CUSIP: | 94974BGC8 |
2